"Still some question about aerosol but likely some degree of aerosol," Anthony Fauci, the head of the US National Institute of Allergy and Infectious Diseases, said by video during a panel session at a Covid-19 conference organized by the International AIDS Society.
Fauci on Thursday had said it was a "reasonable assumption" that airborne transmission was occurring even though there was not a lot of solid evidence behind it. The WHO urged more studies on the issue.
The number of cases in the United States has surged to more than 3 million as states that quickly reopened bars and restaurants have reported sharp increases.
Fauci said that to battle the global virus, there needed to be multiple vaccine candidates. Vaccine makers are aiming to have hundreds of millions of doses ready for early next year and as many as 1 billion in some cases, he said.
"The companies that we are dealing with are already in discussions to start gearing up to make hundreds of millions of doses and a couple of the companies are promising that they would have a billion doses within a year or so after," Fauci said.
The United States has poured billions of dollars into vaccine efforts at Johnson & Johnson, Moderna, Novavax and AstraZeneca.
J&J has said it is aiming for 1 billion doses. Pfizer and BioNTech are also pursuing a vaccine and have said they aim to have 1.2 billion doses by the end of 2021.
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)